{"nct_id":"NCT06241118","title":"A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor","status":"RECRUITING","status_verified_date":"2025-07","start_date":"2024-02-29","start_date_type":"ACTUAL","primary_completion_date":"2026-05-25","primary_completion_date_type":"ESTIMATED","completion_date":"2026-09-14","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["SNY"]}